BEDFORD, Mass. - Stoke Therapeutics, Inc. (NASDAQ: STOK) shares dropped 4.1% after the biotechnology company announced its CEO Edward M. Kaye will step down, overshadowing better-than-expected fourth ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Exelixis, Inc.

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

It’s a tough job analysing share prices and company performances in the middle of a sharp share market downturn, but ...

Insiders are still scooping up shares of stocks, including huge buys at two energy companies, an apparel retailer, and a ...

With a promising outlook for PTC India and Piramal Pharma, Bajaj Broking identifies key stock picks poised for over 15% ...

Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks ...

Abecma made $406 million in 2024, of which BMS paid $43 million to 2seventy bio as part of their profit-sharing agreement.

Brokerages have revealed a favourable outlook for the stock with the acquisition expected to be completed by the second half of 2025.

Here are three ASX shares that could be top picks for investors after the market selloff. Let's see what Bell Potter is ...